Can pharmacokinetic studies assess the pulmonary fate of dry powder inhaler formulations of fluticasone propionate?

G Hochhaus, MJ Chen, A Kurumaddali, U Schilling… - The AAPS journal, 2021 - Springer
In the context of streamlining generic approval, this study assessed whether
pharmacokinetics (PK) could elucidate the pulmonary fate of orally inhaled drug products …
被引用次数：18 相关文章

Can Pharmacokinetic Studies Assess the Pulmonary Fate of Dry Powder Inhaler Formulations of Fluticasone Propionate?

G Hochhaus, MJ Chen, A Kurumaddali, U Schilling… - 2021 - pubmed.ncbi.nlm.nih.gov
In the context of streamlining generic approval, this study assessed whether
pharmacokinetics (PK) could elucidate the pulmonary fate of orally inhaled drug products …

Can Pharmacokinetic Studies Assess the Pulmonary Fate of Dry Powder Inhaler Formulations of Fluticasone Propionate?

G Hochhaus, MJ Chen, A Kurumaddali… - AAPS …, 2021 - researchportal.bath.ac.uk
In the context of streamlining generic approval, this study assessed whether
pharmacokinetics (PK) could elucidate the pulmonary fate of orally inhaled drug products …

[引用][C] Correction to: Can Pharmacokinetic Studies Assess the Pulmonary Fate of Dry Powder Inhaler Formulations of Fluticasone Propionate?

G Hochhaus, MJ Chen, A Kurumaddali, U Schilling… - The AAPS Journal, 2022 - Springer
Correction to: Can Pharmacokinetic Studies Assess the Pulmonary Fate of Dry Powder
Inhaler Formulations of Fluticasone Propionat Page 1 Vol.:(0123456789) https://doi.org/10.1208/s12248-021-00655-0 …
[HTML] nih.gov

[HTML][HTML] Can Pharmacokinetic Studies Assess the Pulmonary Fate of Dry Powder Inhaler Formulations of Fluticasone Propionate?

G Hochhaus, MJ Chen, A Kurumaddali… - The AAPS …, 2021 - ncbi.nlm.nih.gov
In the context of streamlining generic approval, this study assessed whether
pharmacokinetics (PK) could elucidate the pulmonary fate of orally inhaled drug products …
[PDF] google.com

[PDF][PDF] Can pharmacokinetic studies assess the pulmonary fate of dry powder inhaler formulations of fluticasone propionate?

G Hochhaus, MJ Chen, A Kurumaddali… - The AAPS …, 2021 - drive.google.com
In the context of streamlining generic approval, this study assessed whether
pharmacokinetics (PK) could elucidate the pulmonary fate of orally inhaled drug products …

Can Pharmacokinetic Studies Assess the Pulmonary Fate of Dry Powder Inhaler Formulations of Fluticasone Propionate?

G Hochhaus, MJ Chen, A Kurumaddali… - The AAPS …, 2021 - europepmc.org
In the context of streamlining generic approval, this study assessed whether
pharmacokinetics (PK) could elucidate the pulmonary fate of orally inhaled drug products …

Correction to: Can Pharmacokinetic Studies Assess the Pulmonary Fate of Dry Powder Inhaler Formulations of Fluticasone Propionate?(The AAPS Journal,(2021), 23 …

G Hochhaus, MJ Chen, A Kurumaddali… - AAPS …, 2022 - researchportal.bath.ac.uk
Correction to: Can Pharmacokinetic Studies Assess the Pulmonary Fate of Dry Powder Inhaler
Formulations of Fluticasone Propionate? (The AAPS Journal, (2021), 23, 3, (48) …

Correction to: Can Pharmacokinetic Studies Assess the Pulmonary Fate of Dry Powder Inhaler Formulations of Fluticasone Propionate?

G Hochhaus, MJ Chen, A Kurumaddali… - The AAPS …, 2021 - pubmed.ncbi.nlm.nih.gov
Correction to: Can Pharmacokinetic Studies Assess the Pulmonary Fate of Dry Powder
Inhaler Formulations of Fluticasone Propionate? Correction to: Can Pharmacokinetic …

Can Pharmacokinetic Studies Assess the Pulmonary Fate of Dry Powder Inhaler Formulations of Fluticasone Propionate?

G Hochhaus, MJ Chen, A Kurumaddali… - The AAPS …, 2021 - europepmc.org
In the context of streamlining generic approval, this study assessed whether
pharmacokinetics (PK) could elucidate the pulmonary fate of orally inhaled drug products …